Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Clinical trial NCT00030186 · COMPLETED

Trial details

NCT number: NCT00030186
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid

Start date: 2002-01-01
Primary completion: 2003-02-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.